Glucagon-like peptide 2 increases efficacy of distraction enterogenesis

Journal of Surgical Research

Volumn 184, Issue 1, 2013, Pages 365-373

  Sueyoshi, Ryo ^a   Ralls, Matthew W ^a   Teitelbaum, Daniel H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cell proliferation; Distraction induced growth; Enterogenesis; GLP 2; Microfil; Polyethylene glycol (PEG); Vascularity

Indexed keywords

CYCLINE; FIBROBLAST GROWTH FACTOR 1; GLUCAGON LIKE PEPTIDE 2; MACROGOL; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISTRACTION ENTEROGENESIS; DRUG EFFICACY; EPITHELIUM CELL; IMMUNOFLUORESCENCE TEST; INTESTINE; MALE; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR WEIGHT; MORPHOLOGY; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT BOWEL SYNDROME; TISSUE GROWTH; VOLUMETRY;

EID: 84884672119     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.03.089     Document Type: Article

References (40)

1. DeLegge M, Alsolaiman MM, Barbour E, et al. Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Where are we today. Dig Dis Sci 2007;52:876.
2. Squires RH, Duggan C, Teitelbaum DH, et al. Natural History of Pediatric Intestinal Failure: Initial Report from the Pediatric Intestinal Failure Consortium. J Pediatr 2012;161: 723.
3. Spencer AU, Neaga A, West B, et al. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg 2005; 242:403.
4. Miyasaka EA, Okawada M, Utter B, et al. Application of distractive forces to the small intestine: defining safe limits. J Surg Res 2010;163:169.
5. Bianchi A. Intestinal loop lengtheningea technique for increasing small intestinal length. J Pediatr Surg 1980;15:145.
6. Kimura K, Soper RT. Isolated bowel segment (model 1): creation by myoenteropexy. J Pediatr Surg 1990;25:512.
7. Kim HB, Lee PW, Garza J, et al. Serial transverse enteroplasty for short bowel syndrome: a case report. J Pediatr Surg 2003; 38:881.
8. Sudan D, Thompson J, Botha J, et al. Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg 2007;246:593. Discussion 594.
9. Lao OB, Healey PJ, Perkins JD, et al. Outcomes in children after intestinal transplant. Pediatrics 2010;125:e550.
10. Koga H, Sun X, Yang H, et al. Distraction-induced intestinal enterogenesis: preservation of intestinal function and lengthening after reimplantation into normal jejunum. Ann Surg 2012;255:302.
11. Park J, Puapong DP, Wu BM, Atkinson JB, Dunn JC. Enterogenesis by mechanical lengthening: morphology and function of the lengthened small intestine. J Pediatr Surg 2004;39:1823.
12. Puapong DP, Wu BM, Lam MM, Atkinson JB, Dunn JC. Distension enterogenesis: increasing the size and function of small intestine. J Pediatr Surg 2006;41:763.
13. Okawada M, Mustafa Maria H, Teitelbaum DH. Distraction induced enterogenesis: a unique mouse model using polyethylene glycol. J Surg Res 2011;170:41.
14. Brubaker PL, Crivici A, Izzo A, et al. Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide- 2. Endocrinology 1997;138:4837.
15. Rowland KJ, Brubaker PL. The "cryptic" mechanism of action of glucagon-like peptide-2. Am J Physiol Gastrointest Liver Physiol 2011;301:28.
16. Drucker DJ, Deforest L, Brubaker PL. Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon- likepeptide2.AmJPhysiol -Gastrointest Liver Physiol 1997;273:G1252.
17. Tsai CH, Hill M, Drucker DJ. Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am J Physiol - Gastrointest Liver Physiol 1997;272:G662.
18. Tsai CH. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 1997;273:E77.
19. Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005;54:1224.
20. Martin GR, Beck PL, Sigalet DL. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World J Gastroenterol 2006;26:4117.
21. Bremholm L, Hornum M, Henriksen BM, Larsen S, Holst JJ. Glucagon-like peptide-2 increases mesenteric blood flow in humans. Scand J Gastroenterol 2009;44:314.
22. Bremholm L, Hornum M, Andersen UB, Holst JJ. The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters. Regul Pept 2010;159:67.
23. Stephens J, Stoll B, Cottrell J, et al. Glucagon-like peptide-2 acutely increases proximal small intestinal blood flow in TPN-fed neonatal piglets. Am J Physiol Regul Integr Comp Physiol 2006;290:15.
24. Guan X, Karpen HE, Stephens J, et al. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 2006;130:150.
25. Feng Y, Holst JJ, Teitelbaum DH. Total parenteral nutrition (TPN)-associated atrophy is associated with loss of intestinal epithelial cell (EC) migration: modulation of action by epidermal growth factor (EGF) and glucagon-like peptide-2 (GLP-2). Gastroenterology 2011;140:S-170.
26. Spencer A, Yang H, Haxhija E, et al. Reduced Severity of a Mouse Colitis Model with Angiotensin Converting Enzyme Inhibition. Digestive Diseases and Sciences. Springer: Netherlands; 2007:1060.
27. Selvey S, Thompson EW, Matthaei K, et al. Beta-actindan unsuitable internal control for RT-PCR. Mol Cell Probes 2001; 15:307.
28. Dube PE, Forse CL, Bahrami J, Brubaker PL. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. astroenterology 2006; 131:589.
29. Feng Y, Teitelbaum DH. Epidermal growth factor/TNFa transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition. Am J Physiol Gastrointest Liver Physiol 2012;302:10.
30. Ralls MW, Sueyoshi R, Herman RS, et al. Mesenteric neovascularization with distraction-induced intestinal growth: enterogenesis. Pediatr Surg Int 2012;16:16.
31. Brinkman AS, Murali SG, Hitt S, et al. Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure. Am J Physiol Gastrointest Liver Physiol 2012;303:28.
32. Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009;58:1091.
33. Sigalet DL, Wallace LE, Holst JJ, et al. Enteric neural pathways mediate the anti-inflammatory actions of glucagonlike peptide 2. Am J Physiol Gastrointest Liver Physiol 2007; 293:29.
34. Cheeseman CI. Up-regulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol 1997;273:R1965.
35. Drucker DJ, Erlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 1996;93:7911.
36. Garrison AP, Dekaney CM, von Allmen DC, et al. Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion. Am J Physiol Gastrointest Liver Physiol 2009; 296:31.
37. Guan X, Stoll B, Lu X, et al. GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxidedependent in TPN-fed piglets 1. Gastroenterology 2003; 125:136.
38. Hoyerup P, Hellstrom PM, Schmidt PT, et al. Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser Doppler flowmetry in end-jejunostomy short bowel syndrome patients. Regul Pept 2012;16:00243.
39. Martin GR, Wallace LE, Sigalet DL. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2004;286:12.
40. Ramsanahie A, Duxbury MS, Grikscheit TC, et al. Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine. Am J Physiol Gastrointest Liver Physiol 2003;285:14.